The Latin America, Middle East and Africa Recombinant Proteins Market would witness market growth of 14.0% CAGR during the forecast period (2022-2028).
The desire for novel, tailored medications, rise in cancer patients, and other industrial requirements like detergent and diagnostics are all projected to contribute to the total recombinant protein market experiencing considerable growth throughout the forecast period. In addition, subsequent generations of recombinant proteins made some advancements over the prior generation.
The second generation of recombinant proteins included proteins with improved qualities including selectivity, biodistribution, and efficacy, similar to the first generation, which included native protein structures. The third generation of recombinant proteins also included new formulations and administration methods with improved efficacy and security. Therefore, product innovation is the main driver of the recombinant protein market's expansion.
The United Arab Emirates has transformed into a prosperous, modern nation with a Western way of life from a developing nation with a sizable nomadic population. Certainly, this economic development has given UAE inhabitants social benefits and possibilities, including a high and rising life expectancy. But, a serious issue with chronic diseases, notably cardiovascular risk associated with obesity, has been exacerbated by fast industrialization and urbanization.
The Brazil market dominated the LAMEA Recombinant Proteins Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $45.3 million by 2028. The Argentina market is experiencing a CAGR of 14.6% during (2022 - 2028). Additionally, The UAE market would display a CAGR of 13.6% during (2022 - 2028).
Based on Product, the market is segmented into Growth Factors & Chemokines, Recombinant Metabolic Enzymes, Adhesion Molecules & Receptors, Structural Proteins, Membrane Proteins, Kinase Proteins & Regulatory Proteins, Immune Response Proteins, and Others. Based on End User, the market is segmented into Pharmaceutical & Biopharmaceutical Companies, Biotechnology Companies, Academic Research Institutes, Contract Research Organizations, and Others. Based on Application, the market is segmented into Drug Discovery & Development, Academic Research Studies, Biopharmaceutical Production, Diagnostics, Biotechnology Research, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Global Recombinant Proteins Market is Predict to reach $2.6 Billion by 2028, at a CAGR of 10.8%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Bio-Techne Corporation, Thermo Fisher Scientific, Inc., Merck Group, Bio-Rad Laboratories, Inc., Abcam plc, Genscript Biotech Corporation, Miltenyi Biotec B.V. & Co. KG, Proteintech Group, Inc., BPS Bioscience, Inc., and RayBiotech Life, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Product
- Growth Factors & Chemokines
- Recombinant Metabolic Enzymes, Adhesion Molecules & Receptors
- Structural Proteins
- Membrane Proteins
- Kinase Proteins & Regulatory Proteins
- Immune Response Proteins
- Others
By End User
- Pharmaceutical & Biopharmaceutical Companies
- Biotechnology Companies
- Academic Research Institutes
- Contract Research Organizations
- Others
By Application
- Drug Discovery & Development
- Academic Research Studies
- Biopharmaceutical Production
- Diagnostics
- Biotechnology Research
- Others
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Bio-Techne Corporation
- Thermo Fisher Scientific, Inc.
- Merck Group
- Bio-Rad Laboratories, Inc.
- Abcam plc
- Genscript Biotech Corporation
- Miltenyi Biotec B.V. & Co. KG
- Proteintech Group, Inc.
- BPS Bioscience, Inc.
- RayBiotech Life, Inc.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Recombinant Proteins Market, by Product
1.4.2 LAMEA Recombinant Proteins Market, by End User
1.4.3 LAMEA Recombinant Proteins Market, by Application
1.4.4 LAMEA Recombinant Proteins Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies Deployed in Recombinant Proteins Market
Chapter 4. LAMEA Recombinant Proteins Market by Product
4.1 LAMEA Growth Factors & Chemokines Market by Country
4.2 LAMEA Recombinant Metabolic Enzymes, Adhesion Molecules & Receptors Market by Country
4.3 LAMEA Structural Proteins Market by Country
4.4 LAMEA Membrane Proteins Market by Country
4.5 LAMEA Kinase Proteins & Regulatory Proteins Market by Country
4.6 LAMEA Immune Response Proteins Market by Country
4.7 LAMEA Others Market by Country
Chapter 5. LAMEA Recombinant Proteins Market by End User
5.1 LAMEA Pharmaceutical & Biopharmaceutical Companies Market by Country
5.2 LAMEA Biotechnology Companies Market by Country
5.3 LAMEA Academic Research Institutes Market by Country
5.4 LAMEA Contract Research Organizations Market by Country
5.5 LAMEA Others Market by Country
Chapter 6. LAMEA Recombinant Proteins Market by Application
6.1 LAMEA Drug Discovery & Development Market by Country
6.2 LAMEA Academic Research Studies Market by Country
6.3 LAMEA Biopharmaceutical Production Market by Country
6.4 LAMEA Diagnostics Market by Country
6.5 LAMEA Biotechnology Research Market by Country
6.6 LAMEA Others Market by Country
Chapter 7. LAMEA Recombinant Proteins Market by Country
7.1 Brazil Recombinant Proteins Market
7.1.1 Brazil Recombinant Proteins Market by Product
7.1.2 Brazil Recombinant Proteins Market by End User
7.1.3 Brazil Recombinant Proteins Market by Application
7.2 Argentina Recombinant Proteins Market
7.2.1 Argentina Recombinant Proteins Market by Product
7.2.2 Argentina Recombinant Proteins Market by End User
7.2.3 Argentina Recombinant Proteins Market by Application
7.3 UAE Recombinant Proteins Market
7.3.1 UAE Recombinant Proteins Market by Product
7.3.2 UAE Recombinant Proteins Market by End User
7.3.3 UAE Recombinant Proteins Market by Application
7.4 Saudi Arabia Recombinant Proteins Market
7.4.1 Saudi Arabia Recombinant Proteins Market by Product
7.4.2 Saudi Arabia Recombinant Proteins Market by End User
7.4.3 Saudi Arabia Recombinant Proteins Market by Application
7.5 South Africa Recombinant Proteins Market
7.5.1 South Africa Recombinant Proteins Market by Product
7.5.2 South Africa Recombinant Proteins Market by End User
7.5.3 South Africa Recombinant Proteins Market by Application
7.6 Nigeria Recombinant Proteins Market
7.6.1 Nigeria Recombinant Proteins Market by Product
7.6.2 Nigeria Recombinant Proteins Market by End User
7.6.3 Nigeria Recombinant Proteins Market by Application
7.7 Rest of LAMEA Recombinant Proteins Market
7.7.1 Rest of LAMEA Recombinant Proteins Market by Product
7.7.2 Rest of LAMEA Recombinant Proteins Market by End User
7.7.3 Rest of LAMEA Recombinant Proteins Market by Application
Chapter 8. Company Profiles
8.1 Bio-Techne Corporation
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.5.2 Product Launches and Product Expansions:
8.2 Thermo Fisher Scientific, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Acquisition and Mergers:
8.3 Merck Group
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.4 Bio-Rad laboratories, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 Recent strategies and developments:
8.4.5.1 Product Launches and Product Expansions:
8.5 Abcam plc
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.6 Genscript Biotech Corporation
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Regional & Segmental Analysis
8.6.4 Research & Development Expenses
8.7 Miltenyi Biotech B.V. & Co. KG
8.7.1 Company Overview
8.8 Proteintech Group, Inc.
8.8.1 Company Overview
8.8.2 Recent strategies and developments:
8.8.2.1 Acquisition and Mergers:
8.9 BPS Bioscience, Inc.
8.9.1 Company Overview
8.10. RayBiotech Life, Inc.
8.10.1 Company Overview
TABLE 1 LAMEA Recombinant Proteins Market, 2018 - 2021, USD Million
TABLE 2 LAMEA Recombinant Proteins Market, 2022 - 2028, USD Million
TABLE 3 LAMEA Recombinant Proteins Market by Product, 2018 - 2021, USD Million
TABLE 4 LAMEA Recombinant Proteins Market by Product, 2022 - 2028, USD Million
TABLE 5 LAMEA Growth Factors & Chemokines Market by Country, 2018 - 2021, USD Million
TABLE 6 LAMEA Growth Factors & Chemokines Market by Country, 2022 - 2028, USD Million
TABLE 7 LAMEA Recombinant Metabolic Enzymes, Adhesion Molecules & Receptors Market by Country, 2018 - 2021, USD Million
TABLE 8 LAMEA Recombinant Metabolic Enzymes, Adhesion Molecules & Receptors Market by Country, 2022 - 2028, USD Million
TABLE 9 LAMEA Structural Proteins Market by Country, 2018 - 2021, USD Million
TABLE 10 LAMEA Structural Proteins Market by Country, 2022 - 2028, USD Million
TABLE 11 LAMEA Membrane Proteins Market by Country, 2018 - 2021, USD Million
TABLE 12 LAMEA Membrane Proteins Market by Country, 2022 - 2028, USD Million
TABLE 13 LAMEA Kinase Proteins & Regulatory Proteins Market by Country, 2018 - 2021, USD Million
TABLE 14 LAMEA Kinase Proteins & Regulatory Proteins Market by Country, 2022 - 2028, USD Million
TABLE 15 LAMEA Immune Response Proteins Market by Country, 2018 - 2021, USD Million
TABLE 16 LAMEA Immune Response Proteins Market by Country, 2022 - 2028, USD Million
TABLE 17 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 18 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 19 LAMEA Recombinant Proteins Market by End User, 2018 - 2021, USD Million
TABLE 20 LAMEA Recombinant Proteins Market by End User, 2022 - 2028, USD Million
TABLE 21 LAMEA Pharmaceutical & Biopharmaceutical Companies Market by Country, 2018 - 2021, USD Million
TABLE 22 LAMEA Pharmaceutical & Biopharmaceutical Companies Market by Country, 2022 - 2028, USD Million
TABLE 23 LAMEA Biotechnology Companies Market by Country, 2018 - 2021, USD Million
TABLE 24 LAMEA Biotechnology Companies Market by Country, 2022 - 2028, USD Million
TABLE 25 LAMEA Academic Research Institutes Market by Country, 2018 - 2021, USD Million
TABLE 26 LAMEA Academic Research Institutes Market by Country, 2022 - 2028, USD Million
TABLE 27 LAMEA Contract Research Organizations Market by Country, 2018 - 2021, USD Million
TABLE 28 LAMEA Contract Research Organizations Market by Country, 2022 - 2028, USD Million
TABLE 29 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 30 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 31 LAMEA Recombinant Proteins Market by Application, 2018 - 2021, USD Million
TABLE 32 LAMEA Recombinant Proteins Market by Application, 2022 - 2028, USD Million
TABLE 33 LAMEA Drug Discovery & Development Market by Country, 2018 - 2021, USD Million
TABLE 34 LAMEA Drug Discovery & Development Market by Country, 2022 - 2028, USD Million
TABLE 35 LAMEA Academic Research Studies Market by Country, 2018 - 2021, USD Million
TABLE 36 LAMEA Academic Research Studies Market by Country, 2022 - 2028, USD Million
TABLE 37 LAMEA Biopharmaceutical Production Market by Country, 2018 - 2021, USD Million
TABLE 38 LAMEA Biopharmaceutical Production Market by Country, 2022 - 2028, USD Million
TABLE 39 LAMEA Diagnostics Market by Country, 2018 - 2021, USD Million
TABLE 40 LAMEA Diagnostics Market by Country, 2022 - 2028, USD Million
TABLE 41 LAMEA Biotechnology Research Market by Country, 2018 - 2021, USD Million
TABLE 42 LAMEA Biotechnology Research Market by Country, 2022 - 2028, USD Million
TABLE 43 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 44 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 45 LAMEA Recombinant Proteins Market by Country, 2018 - 2021, USD Million
TABLE 46 LAMEA Recombinant Proteins Market by Country, 2022 - 2028, USD Million
TABLE 47 Brazil Recombinant Proteins Market, 2018 - 2021, USD Million
TABLE 48 Brazil Recombinant Proteins Market, 2022 - 2028, USD Million
TABLE 49 Brazil Recombinant Proteins Market by Product, 2018 - 2021, USD Million
TABLE 50 Brazil Recombinant Proteins Market by Product, 2022 - 2028, USD Million
TABLE 51 Brazil Recombinant Proteins Market by End User, 2018 - 2021, USD Million
TABLE 52 Brazil Recombinant Proteins Market by End User, 2022 - 2028, USD Million
TABLE 53 Brazil Recombinant Proteins Market by Application, 2018 - 2021, USD Million
TABLE 54 Brazil Recombinant Proteins Market by Application, 2022 - 2028, USD Million
TABLE 55 Argentina Recombinant Proteins Market, 2018 - 2021, USD Million
TABLE 56 Argentina Recombinant Proteins Market, 2022 - 2028, USD Million
TABLE 57 Argentina Recombinant Proteins Market by Product, 2018 - 2021, USD Million
TABLE 58 Argentina Recombinant Proteins Market by Product, 2022 - 2028, USD Million
TABLE 59 Argentina Recombinant Proteins Market by End User, 2018 - 2021, USD Million
TABLE 60 Argentina Recombinant Proteins Market by End User, 2022 - 2028, USD Million
TABLE 61 Argentina Recombinant Proteins Market by Application, 2018 - 2021, USD Million
TABLE 62 Argentina Recombinant Proteins Market by Application, 2022 - 2028, USD Million
TABLE 63 UAE Recombinant Proteins Market, 2018 - 2021, USD Million
TABLE 64 UAE Recombinant Proteins Market, 2022 - 2028, USD Million
TABLE 65 UAE Recombinant Proteins Market by Product, 2018 - 2021, USD Million
TABLE 66 UAE Recombinant Proteins Market by Product, 2022 - 2028, USD Million
TABLE 67 UAE Recombinant Proteins Market by End User, 2018 - 2021, USD Million
TABLE 68 UAE Recombinant Proteins Market by End User, 2022 - 2028, USD Million
TABLE 69 UAE Recombinant Proteins Market by Application, 2018 - 2021, USD Million
TABLE 70 UAE Recombinant Proteins Market by Application, 2022 - 2028, USD Million
TABLE 71 Saudi Arabia Recombinant Proteins Market, 2018 - 2021, USD Million
TABLE 72 Saudi Arabia Recombinant Proteins Market, 2022 - 2028, USD Million
TABLE 73 Saudi Arabia Recombinant Proteins Market by Product, 2018 - 2021, USD Million
TABLE 74 Saudi Arabia Recombinant Proteins Market by Product, 2022 - 2028, USD Million
TABLE 75 Saudi Arabia Recombinant Proteins Market by End User, 2018 - 2021, USD Million
TABLE 76 Saudi Arabia Recombinant Proteins Market by End User, 2022 - 2028, USD Million
TABLE 77 Saudi Arabia Recombinant Proteins Market by Application, 2018 - 2021, USD Million
TABLE 78 Saudi Arabia Recombinant Proteins Market by Application, 2022 - 2028, USD Million
TABLE 79 South Africa Recombinant Proteins Market, 2018 - 2021, USD Million
TABLE 80 South Africa Recombinant Proteins Market, 2022 - 2028, USD Million
TABLE 81 South Africa Recombinant Proteins Market by Product, 2018 - 2021, USD Million
TABLE 82 South Africa Recombinant Proteins Market by Product, 2022 - 2028, USD Million
TABLE 83 South Africa Recombinant Proteins Market by End User, 2018 - 2021, USD Million
TABLE 84 South Africa Recombinant Proteins Market by End User, 2022 - 2028, USD Million
TABLE 85 South Africa Recombinant Proteins Market by Application, 2018 - 2021, USD Million
TABLE 86 South Africa Recombinant Proteins Market by Application, 2022 - 2028, USD Million
TABLE 87 Nigeria Recombinant Proteins Market, 2018 - 2021, USD Million
TABLE 88 Nigeria Recombinant Proteins Market, 2022 - 2028, USD Million
TABLE 89 Nigeria Recombinant Proteins Market by Product, 2018 - 2021, USD Million
TABLE 90 Nigeria Recombinant Proteins Market by Product, 2022 - 2028, USD Million
TABLE 91 Nigeria Recombinant Proteins Market by End User, 2018 - 2021, USD Million
TABLE 92 Nigeria Recombinant Proteins Market by End User, 2022 - 2028, USD Million
TABLE 93 Nigeria Recombinant Proteins Market by Application, 2018 - 2021, USD Million
TABLE 94 Nigeria Recombinant Proteins Market by Application, 2022 - 2028, USD Million
TABLE 95 Rest of LAMEA Recombinant Proteins Market, 2018 - 2021, USD Million
TABLE 96 Rest of LAMEA Recombinant Proteins Market, 2022 - 2028, USD Million
TABLE 97 Rest of LAMEA Recombinant Proteins Market by Product, 2018 - 2021, USD Million
TABLE 98 Rest of LAMEA Recombinant Proteins Market by Product, 2022 - 2028, USD Million
TABLE 99 Rest of LAMEA Recombinant Proteins Market by End User, 2018 - 2021, USD Million
TABLE 100 Rest of LAMEA Recombinant Proteins Market by End User, 2022 - 2028, USD Million
TABLE 101 Rest of LAMEA Recombinant Proteins Market by Application, 2018 - 2021, USD Million
TABLE 102 Rest of LAMEA Recombinant Proteins Market by Application, 2022 - 2028, USD Million
TABLE 103 Key Information – Bio-Techne Corporation
TABLE 104 Key Information – Thermo Fisher Scientific, Inc.
TABLE 105 key Information – Merck GrouP
TABLE 106 Key Information – Bio-Rad Laboratories, Inc.
TABLE 107 key information – Abcam plc
TABLE 108 Key information – Genscript Biotech Corporation
TABLE 109 Key information – Miltenyi Biotec B.V. & Co. KG
TABLE 110 Key Information – Proteintech Group, Inc.
TABLE 111 Key Information – BPS Bioscience, Inc.
TABLE 112 Key Information – RayBiotech Life, Inc.
List of Figures
FIG 1 Methodology for the research